Results 1 to 10 of about 84,496 (180)
Zdravniški Vestnik, 2011 Retinal vein occlusion is a common disease, especially in the elderly, and is associated with significant visual morbidity, as a consequence of persistent macular oedema, macular ischemia, and in the advanced stages of the disease, due to retinal or iris
Polona Jaki Mekjavič +2 more
doaj +8 more sources
Indian Journal of Ophthalmology, 1994 In this review of the retinal vein occlusion (RVO), I have summarized recent advances on several controversial and clinically important topics: classification of RVO into six distinct clinical entities; pathogeneses and demographic characteristics of ...
Hayreh Sohan
doaj +3 more sources
Kerala Journal of Ophthalmology, 2016 Retinal vein occlusion is commonly seen in the elderly.This article aims to comprehensively discuss the etiology,classification,risk factors and latest modalities of management of this condition.
Rodney Morris
doaj +2 more sources
Frontiers in Neurology, 2021 Retinal vein changes, which can be observed on clinical exam or ophthalmic imaging, are promising non-invasive biomarkers for elevated intracranial pressure (ICP) as a complement to other markers of high ICP including optic nerve head swelling.
Heather E. Moss, Heather E. Moss
doaj +1 more source
10-year fundus tessellation progression and retinal vein occlusion [PDF]
International Journal of Ophthalmology, 2018 AIM: To access the 10-year fundus tessellation progression in patients with retinal vein occlusion. METHODS: The Beijing Eye Study 2001/2011 is a population-based longitudinal study.
Yan-Ni Yan +9 more
doaj +1 more source
Acta Dermato-Venereologica, 2022 Psoriasis is a chronic inflammatory skin disease imparting increased risk of cardiovascular diseases. Until now, few studies have reported an increased incidence of ophthalmological retinal vasculopathy in individuals with psoriasis.
Seung Woo Lee +3 more
doaj +1 more source
Early CRT monitoring using time-domain optical coherence tomography does not add to visual acuity for predicting visual loss in patients with central retinal vein occlusion treated with intravitreal ranibizumab:A secondary analysis of trial data [PDF]
, 2017 Our primary purpose was to assess the clinical (predictive) validity of central retinal thickness (CRT) and best corrected visual acuity (BCVA) at 1 week and 1 month after starting treatment with ranibizumab for central retinal vein occlusion.
Bell, Katy J L +8 more
core +2 more sources
Comparison between “early” or “late” intravitreal injection of dexamethasone implant in branch (BRVO) or central (CRVO) retinal vein occlusion: six months follow-up [PDF]
, 2017 AIM: The aim of this study was to compare early and late injections of intravitreal dexamethasone implant in patients affected by central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO) with a six-months follow-up.
AUTOLITANO, MONICA +6 more
core +1 more source
Adverse events associated with intraocular injection of anti-VEGF(bevacizumab) in retinal vein ccclusion: a case report [PDF]
, 2015 Introduction: Antiangiogenic agents are often administered for treatment of Branch Retinal Vein Occlusion (BRVO). Among them, Bevacizumab has noticeable antiangiogenic and antiedemigenic properties and possesses great capacity to penetrate the retinal ...
ARTICO, Marco +7 more
core +1 more source
Asia-Pacific Journal of Ophthalmology, 2012 Retinal vein occlusions (RVOs) are second to diabetic retinopathy in the prevalence as retinal vascular disorder and are characterized by dilatation of the retinal veins with retinal and subretinal hemorrhages, macular edema, hard retinal exudates, retinal ischemia, and consequent atrophy of the retina and optic nerve.
Jost B, Jonas, Dennis S C, Lam
openaire +2 more sources